1. Home
  2. FUBO vs EYPT Comparison

FUBO vs EYPT Comparison

Compare FUBO & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo fuboTV Inc.

FUBO

fuboTV Inc.

HOLD

Current Price

$2.71

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo EyePoint Pharmaceuticals Inc.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$17.53

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUBO
EYPT
Founded
2009
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
FUBO
EYPT
Price
$2.71
$17.53
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$5.35
$29.60
AVG Volume (30 Days)
10.3M
1.3M
Earning Date
11-03-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.34
N/A
Revenue
$1,616,726,000.00
$42,339,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.99
N/A
P/E Ratio
$7.99
N/A
Revenue Growth
1.70
N/A
52 Week Low
$1.21
$3.91
52 Week High
$6.45
$19.11

Technical Indicators

Market Signals
Indicator
FUBO
EYPT
Relative Strength Index (RSI) 35.57 66.36
Support Level $2.55 $16.52
Resistance Level $2.76 $17.40
Average True Range (ATR) 0.11 1.08
MACD 0.01 0.02
Stochastic Oscillator 37.80 71.27

Price Performance

Historical Comparison
FUBO
EYPT

About FUBO fuboTV Inc.

FuboTV Inc is a sports-first, live TV streaming company offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. It offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality suited to their preferences. The company has one operating segment, the streaming business. Geographically, the company generates a majority of its revenue from the United States and also has a presence in other markets.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: